Fever in Returned Travelers: Review of Hospital Admissions for a 3-year Period
Overview
Affiliations
We reviewed 232 consecutive patients admitted to a tertiary-care hospital under the care of an infectious diseases unit for management of febrile illness acquired overseas. A total of 53% presented to hospital within 1 week of return and 96% within 6 months. Malaria was the most common diagnosis (27% of patients), followed by respiratory tract infection (24%), gastroenteritis (14%), dengue fever (8%), and bacterial pneumonia (6%). Pretravel vaccination may have prevented a number of admissions, including influenza (n=11), typhoid fever (n=8) and hepatitis A (n=6). Compared to those who had not traveled to Africa, those who had were 6 times more likely to present with falciparum than nonfalciparum malaria. An itinerary that included Asia was associated with a 13-fold increased risk of dengue, but a lower risk of malaria. Palpable splenomegaly was associated with an 8-fold risk of malaria and hepatomegaly with a 4-fold risk of malaria. As a cause of fever, bacterial pneumonia was > or =5 times more likely in those who were aged >40 years.
Lovey T, Hasler R, Gautret P, Schlagenhauf P J Travel Med. 2023; 30(5).
PMID: 37310895 PMC: 10481419. DOI: 10.1093/jtm/taad081.
Two cases of COVID-19 presenting with severe malaria: a clinical challenge (case report).
Ayisi-Boateng N, Boampong K, Mensah B, Oduro E, Badu K Pan Afr Med J. 2023; 44:83.
PMID: 37193108 PMC: 10182374. DOI: 10.11604/pamj.2023.44.83.34453.
SARS-CoV-2 and Co-Infection in a Returning Traveler.
Huang Q, Xu W, Wang X, Zhang X, Pan K, Zhang J Front Public Health. 2022; 10:871374.
PMID: 35991037 PMC: 9389161. DOI: 10.3389/fpubh.2022.871374.
Malaria diagnostic methods with the elimination goal in view.
Oyegoke O, Maharaj L, Akoniyon O, Kwoji I, Roux A, Adewumi T Parasitol Res. 2022; 121(7):1867-1885.
PMID: 35460369 PMC: 9033523. DOI: 10.1007/s00436-022-07512-9.
COVID-19 and blood groups: A six-months observational study in Ferrara, Italy.
Greco S, Fabbri N, Bella A, Bonsi B, Violi A, Fortunato V Hematol Rep. 2021; 13(3):9177.
PMID: 34650783 PMC: 8447536. DOI: 10.4081/hr.2021.9177.